Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hoogendoorn-Lips, T. Feenstra, R. Hoogenveen, M. van Genugten, M. Rutten-van Mölken (Rotterdam, Bilthoven, The Netherlands). Projections of the future burden of COPD in the Netherlands by disease severity using a dynamic population model of disease progression. Eur Respir J 2004; 24: Suppl. 48, 4303

Member's Comments

No comment yet.

Related content which might interest you: A new paradigm for classification of disease severity and progression of COPD Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Global cardiovascular disease risk in U.S. adults by severity and presence of COPD Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Epidemiology of COPD: social burden and trends for the future Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management Year: 2006 Distribution of severity of patients with obstructive lung disease in an at risk population Source: Eur Respir J 2004; 24: Suppl. 48, 474s Year: 2004 Present and future costs of COPD in Iceland and Norway: results from the BOLD study Source: Eur Respir J 2009; 34: 850-857 Year: 2009 Impact of stable state symptoms on the future burden of COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Prevalence of cardiovascular disease in COPD patients in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Carers in advanced COPD: impact on the disease and impact of the disease Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 The presence and impact of chronic kidney disease in COPD patients, data from the German COSYCONET cohort Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I Source: Annual Congress 2003 - Burden of asthma Year: 2003 Chronic obstructive pulmonary disease: current burden and future projections Source: Eur Respir J 2006; 27: 397-412 Year: 2006 The association of respiratory health and cardiovascular risk with structural brain disease in patients with COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Will the population ²at risk for COPD² develop COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 218s Year: 2005 Is there any relationship between the duration to diagnosis of COPD and severity of the disease? Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021 The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population Source: Annual Congress 2012 - COPD comorbidities II Year: 2012